NCT07207902Active, not recruiting
Surveillance or Focal Therapy
Surveillance or Focal Therapy (SOFT) for Prostate Cancer
Source: ClinicalTrials.gov · Last updated 6 Oct 2025
Brief summary (registry, in English)
Patients with newly diagnosed low-intermediate risk prostate cancer often are not advised of all the options in an easy to understand way. This trial will show patients a 2 minute animated Explainer video to better understand their treatment options. Patients will choose their treatment choice (surveillance, focal therapy, or standard treatment option) and we will determine disease related anxiety and decision regret scores.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- First submitted
- 7 Apr 2025
- Start date
- 1 Jun 2025
- Primary completion date
- 1 Aug 2026
- Lead sponsor
- Kaiser Permanente
- Diseases
- Prostate cancer
- NCT number
- NCT07207902
What you commit to
- Study type: Interventional
- Planned participants: 400
- From 1 Jun 2025 to the primary completion date, 1 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Latex allergy
- Multifocal or anterior disease
Other
- Anal stenosis
- Prostatic calfcifations
- Gleason grade group 3-5
- Prostate \> 60 cc
Who the study is looking for
- Gleason 3+3 (GG 1) or 3+4 (GG2)
- ≤4 cores
- T1c-T2
- Prostate \< 60cc
- MRI non-focal or PIRADS 3-4 in peripheral gland
- Absence of significant anterior disease
Age in the registry: 40 years to 80 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kaiser Permanente Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.